The European parliamentary election is the second largest democratic exercise in the world.Europe Newsread more
Biden had criticized Kim Jong Un as a "dictator" and a "tyrant" at a recent rally in Philadelphia. North Korean state media responded by calling Biden a "fool of low IQ" among...Politicsread more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Altria shareholders grilled CEO Howard Willard on his $12.8 billion bet on e-cigarette giant Juul at the company's annual shareholder meeting Thursday.
Analysts and investors worried Altria paid too much for its 35% stake in the company and very little say over its operations, especially with the e-cigarette giant facing regulatory scrutiny.
Willard on Thursday defended the terms of the deal, saying the e-cigarette market wasn't growing much before Juul entered it. Altria's own MarkTen products hardly gained traction, prompting Altria to stop selling them in the fall before signing the deal with Juul.
"I'm very pleased for the opportunity to make the investment and believe it will pay dividends down the road," he told analysts.
For more on investing in health-care innovation, click here to join CNBC at our Healthy Returns Summit in New York City on May 21.
Juul finds itself facing public and regulatory scrutiny from critics who say the company fueled a teen vaping "epidemic." A number of lawsuits accuse Juul of intentionally hooking teens on nicotine, the Food and Drug Administration is investigating the company's marketing practices and on Wednesday, the North Carolina attorney general sued Juul.
"JUUL targeted young people as customers. As a result, vaping has become an epidemic among minors," North Carolina Attorney General Josh Stein said in a statement. "JUUL's business practices are not only reckless, they're illegal. And I intend to put a stop to them. We cannot allow another generation of young people to become addicted to nicotine."
Willard in response to a shareholder question on how Altria would make itself less vulnerable to Juul's legal risks said Altria was aware of early litigation when he made the investment in Juul. He said Altria is committed to reducing youth e-cigarette use, including with its support of raising the minimum tobacco buying age to 21.
A judge on Wednesday ruled the Food and Drug Administration needs to start reviewing applications for e-cigarettes. Former FDA Commissioner Scott Gottlieb in 2017 pushed the deadline to 2022, though the FDA earlier this year said it would move that up to 2021.
Willard said Altria will study the decision and he expects the legal process to continue through the next few months or possibly even years with appeals.